Real-World Efficacy of Intravesical Gemcitabine for BCG-Unresponsive Non-muscle-Invasive Bladder Cancer.
Saved in:
| Title: | Real-World Efficacy of Intravesical Gemcitabine for BCG-Unresponsive Non-muscle-Invasive Bladder Cancer. |
|---|---|
| Authors: | Lee HW; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Jung EH; Department of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, Korea., Kim KH; Department of Urology, Pusan National University Hospital, Pusan National University College of Medicine, Busan, Korea., Ha HK; Department of Urology, Pusan National University Hospital, Pusan National University College of Medicine, Busan, Korea., Oh JJ; Department of Urology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea., Kang SH; Department of Urology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea., Jeong SH; Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.; Department of Urology, Seoul National University Hospital, Seoul, Korea., Yuk HD; Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.; Department of Urology, Seoul National University Hospital, Seoul, Korea., Heo JE; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea., Ham WS; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea., Hwang EC; Department of Urology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea., Jung SI; Department of Urology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea., Song W; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Lim B; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Hong B; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Jeong BC; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Seo HK; Department of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, Korea.; Division of Tumor Immunology, Research Institute and Hospital of National Cancer Center, Goyang, Korea.; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea. |
| Source: | Cancer research and treatment [Cancer Res Treat] 2026 Apr; Vol. 58 (2), pp. 591-602. Date of Electronic Publication: 2025 May 12. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2005-9256 |
|---|---|
| DOI: | 10.4143/crt.2025.100 |
